Tags

Type your tag names separated by a space and hit enter

Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes.
Kidney Int. 2017 01; 91(1):204-215.KI

Abstract

Higher diet-dependent nonvolatile acid load is associated with faster chronic kidney disease (CKD) progression, but most studies have used estimated acid load or measured only components of the gold standard, net acid excretion (NAE). Here we measured NAE as the sum of urine ammonium and titratable acidity in 24-hour urines from a random subset of 980 participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. In multivariable models accounting for demographics, comorbidity and kidney function, higher NAE was significantly associated with lower serum bicarbonate (0.17 mEq/l lower serum bicarbonate per 10 mEq/day higher NAE), consistent with a larger acid load. Over a median of 6 years of follow-up, higher NAE was independently associated with a significantly lower risk of the composite of end-stage renal disease or halving of estimated glomerular filtration rate among diabetics (hazard ratio 0.88 per 10 mEq/day higher NAE), but not those without diabetes (hazard ratio 1.04 per 10 mEq/day higher NAE). For comparison, we estimated the nonvolatile acid load as net endogenous acid production using self-reported food frequency questionnaires from 2848 patients and dietary urine biomarkers from 3385 patients. Higher net endogenous acid production based on biomarkers (urea nitrogen and potassium) was modestly associated with faster CKD progression consistent with prior reports, but only among those without diabetes. Results from the food frequency questionnaires were not associated with CKD progression in any group. Thus, disparate results obtained from analyses of nonvolatile acid load directly measured as NAE and estimated from diet suggest a novel hypothesis that the risk of CKD progression related to low NAE or acid load may be due to diet-independent changes in acid production in diabetes.

Authors+Show Affiliations

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA. Electronic address: Julia.scialla@duke.edu.Litholink Corp, Laboratory Corporation of America Holdings, Chicago, Illinois, USA.Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.Kidney Health Research Institute, Geisinger Health System, Danville, Pennsylvania, USA.Department of Medicine, University of Illinois Chicago, Chicago, Illinois, USA.Department of Medicine, University of California, San Francisco, San Francisco, California, USA; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.Department of Biostatistics and Epidemiology and the Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.Department of Biostatistics and Epidemiology and the Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.Department of Medicine, Johns Hopkins University School of Medicine and The Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, Maryland, USA.Department of Family Medicine and Public Health, University of California San Diego, San Diego, California, USA.Division of Nephrology and Hypertension, Department of Medicine, and Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.No affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

27914710

Citation

Scialla, Julia J., et al. "Higher Net Acid Excretion Is Associated With a Lower Risk of Kidney Disease Progression in Patients With Diabetes." Kidney International, vol. 91, no. 1, 2017, pp. 204-215.
Scialla JJ, Asplin J, Dobre M, et al. Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes. Kidney Int. 2017;91(1):204-215.
Scialla, J. J., Asplin, J., Dobre, M., Chang, A. R., Lash, J., Hsu, C. Y., Kallem, R. R., Hamm, L. L., Feldman, H. I., Chen, J., Appel, L. J., Anderson, C. A., & Wolf, M. (2017). Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes. Kidney International, 91(1), 204-215. https://doi.org/10.1016/j.kint.2016.09.012
Scialla JJ, et al. Higher Net Acid Excretion Is Associated With a Lower Risk of Kidney Disease Progression in Patients With Diabetes. Kidney Int. 2017;91(1):204-215. PubMed PMID: 27914710.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes. AU - Scialla,Julia J, AU - Asplin,John, AU - Dobre,Mirela, AU - Chang,Alex R, AU - Lash,James, AU - Hsu,Chi-Yuan, AU - Kallem,Radhakrishna R, AU - Hamm,L Lee, AU - Feldman,Harold I, AU - Chen,Jing, AU - Appel,Lawrence J, AU - Anderson,Cheryl A M, AU - Wolf,Myles, AU - ,, Y1 - 2016/12/01/ PY - 2016/02/12/received PY - 2016/09/01/revised PY - 2016/09/08/accepted PY - 2016/12/5/pubmed PY - 2017/11/3/medline PY - 2016/12/5/entrez KW - chronic kidney disease KW - diabetic nephropathy KW - nutrition SP - 204 EP - 215 JF - Kidney international JO - Kidney Int VL - 91 IS - 1 N2 - Higher diet-dependent nonvolatile acid load is associated with faster chronic kidney disease (CKD) progression, but most studies have used estimated acid load or measured only components of the gold standard, net acid excretion (NAE). Here we measured NAE as the sum of urine ammonium and titratable acidity in 24-hour urines from a random subset of 980 participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. In multivariable models accounting for demographics, comorbidity and kidney function, higher NAE was significantly associated with lower serum bicarbonate (0.17 mEq/l lower serum bicarbonate per 10 mEq/day higher NAE), consistent with a larger acid load. Over a median of 6 years of follow-up, higher NAE was independently associated with a significantly lower risk of the composite of end-stage renal disease or halving of estimated glomerular filtration rate among diabetics (hazard ratio 0.88 per 10 mEq/day higher NAE), but not those without diabetes (hazard ratio 1.04 per 10 mEq/day higher NAE). For comparison, we estimated the nonvolatile acid load as net endogenous acid production using self-reported food frequency questionnaires from 2848 patients and dietary urine biomarkers from 3385 patients. Higher net endogenous acid production based on biomarkers (urea nitrogen and potassium) was modestly associated with faster CKD progression consistent with prior reports, but only among those without diabetes. Results from the food frequency questionnaires were not associated with CKD progression in any group. Thus, disparate results obtained from analyses of nonvolatile acid load directly measured as NAE and estimated from diet suggest a novel hypothesis that the risk of CKD progression related to low NAE or acid load may be due to diet-independent changes in acid production in diabetes. SN - 1523-1755 UR - https://www.unboundmedicine.com/medline/citation/27914710/Higher_net_acid_excretion_is_associated_with_a_lower_risk_of_kidney_disease_progression_in_patients_with_diabetes_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0085-2538(16)30538-5 DB - PRIME DP - Unbound Medicine ER -